Roche Files Mabthera In Rheumatoid Arthritis In Europe - EasyBourse.com

Roche Files Mabthera In Rheumatoid Arthritis In Europe EasyBourse.com VX) said Friday it has submiited Mabthera to the European health authority for extended use in patients suffering rheumatoid arthritis. ... Roche files cancer drug for arthritis approvalReuters all 5 news articles »

Rheumatoid arthritis: The deforming ailment - BusinessDay

Rheumatoid arthritis: The deforming ailment BusinessDay Years back, many believed that rheumatoid arthritis was only a disease of the elderly, but today, children, the young and old alike are affected by it. ... and more »

Glaxo signs drug-development deal with British firm - Philadelphia Inquirer

stv.tv

Glaxo signs drug-development deal with British firm Philadelphia Inquirer GlaxoSmithKline PLC signed a deal yesterday to develop drugs to treat rheumatoid arthritis and other inflammatory diseases. ... GSK signs arthritis drug development collaborationPharmafocus GlaxoSmithKline Signs Research Deal With Chroma TherapeuticsWall Street Journal GlaxoSmithKline unites on arthritis drugHays Pharma Forbes -Reuters -Independent all 45 news articles »

MorphoSys files for Phase 1b/2a trial for MOR103 in rheumatoid ... - Trading Markets (press release)

MorphoSys files for Phase 1b/2a trial for MOR103 in rheumatoid ... Trading Markets (press release) ... of a phase 1b/2a clinical study in patients with active rheumatoid arthritis (RA) for its lead drug MOR103, the company announced on Wednesday. ... MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead ...MarketWatch all 22 news articles »